CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

VNDA Stock Fades After Hetlioz Sleep-Trial Win — Here’s Why

Data ReadoutpositiveHetliozNegative
AI Analysis

Summary

Vanda Pharmaceuticals achieved a positive trial outcome for Hetlioz in a sleep study, but the stock declined following the news announcement.

Importance:5/10
Sentiment:
-0.30
clinical trialsleep disorderstock performance
Related Companies

Read the original article

Published by yahoo_finance on September 30, 2026 5:27 PM

Read Original